Bristol-Myers Squibb Co (NYSE:BMY)
| 55.75 Delayed Data As of 4:00pm ET |  +1.36 / +2.50%Today’s Change | 42.48 Today|||52-Week Range 68.34 | -13.15% Year-to-Date |
BMY Regular Dividend: BMY will begin trading ex-dividend on 04/02/20 with a $0.45 dividend payable to shareholders of record as of 04/03/20.
Latest BMY News | Press Releases
| 4 Reasons Drug Stocks Are a Buy Right Now Mar 30 / MotleyFool.com - Paid Partner Content | 3 Dirt-Cheap Healthcare Stocks to Buy Right Now Mar 27 / MotleyFool.com - Paid Partner Content |
| My Top Healthcare Stocks to Buy in the Market Crash Mar 29 / MotleyFool.com - Paid Partner Content | Bristol Myers Squibb's Multiple Sclerosis Drug, a Potential Blockbuster, Wins FDA Approval Mar 26 / MotleyFool.com - Paid Partner Content |
| My Top 3 Drug Stocks to Buy in the Market Crash Mar 28 / MotleyFool.com - Paid Partner Content | 3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys? Mar 26 / MotleyFool.com - Paid Partner Content |
| Is Bristol Myers Squibb Stock a Buy? Mar 27 / MotleyFool.com - Paid Partner Content | 3 Industries That Are No-Brainer Buys Right Now Mar 26 / MotleyFool.com - Paid Partner Content |
| Better Buy: Geron vs. Acceleron Mar 27 / MotleyFool.com - Paid Partner Content | 3 Reasons Pharma Stocks Are a Buy Right Now Mar 25 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 54.39 |
| Today’s open | 54.30 |
| Day’s range | 54.26 - 56.23 |
| Volume | 28,389,045 |
| Average volume (3 months) | 18,569,590 |
| Market cap | -- |
Data as of 4:00pm ET, 03/31/2020
Growth & Valuation
| Earnings growth (last year) | -33.05% |
| Earnings growth (this year) | +32.25% |
| Earnings growth (next 5 years) | +9.76% |
| Revenue growth (last year) | +15.89% |
| P/E ratio | 27.7 |
| Price/Sales | 4.20 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.15 | +0.34% |
| LLYEli Lilly and Co | +0.18 | +0.13% |
| SNYSanofi | -1.10 | -2.45% |
| ABBVAbbVie | +1.03 | +1.37% |
Data as of 4:46pm ET, 03/31/2020
Financials
| Next reporting date | April 23, 2020 |
| EPS forecast (this quarter) | $1.50 |
| Annual revenue (last year) | $26.1B |
| Annual profit (last year) | $3.4B |
| Net profit margin | 13.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
